Bell Rock Capital’s AstraZeneca AZN Stock Holding History

Bell Rock Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-200	Closed	-$19K	–	82
2019 Q4	$19K	Hold	200	–	–	0.02%	279
2019 Q3	$17K	Hold	200	–	–	0.02%	271
2019 Q2	$16K	Hold	200	–	–	0.01%	279
2019 Q1	$16K	Hold	200	–	–	0.01%	313
2018 Q4	$15K	Hold	200	–	–	0.01%	324
2018 Q3	$16K	Hold	200	–	–	0.01%	327
2018 Q2	$14K	Hold	200	–	–	0.01%	357
2018 Q1	$14K	Hold	200	–	–	0.01%	355
2017 Q4	$14K	Hold	200	–	–	0.01%	337
2017 Q3	$14K	Hold	200	–	–	0.01%	327
2017 Q2	$14K	Hold	200	–	–	0.01%	317
2017 Q1	$12K	Hold	200	–	–	0.01%	291
2016 Q4	$11K	Buy	+200	New	+$11.4K	0.01%	289

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bell Rock Capital's AZN Position: Q1 2020 in Review

Bell Rock Capital sold out of AstraZeneca (AZN) in Q1 2020, closing a stake of 200 shares — an estimated $19K sold.

Bell Rock Capital first reported a position in AZN in Q4 2016 and held it in 13 quarters. The position peaked at $19K in Q4 2019. 603 funds tracked by Wall St. Rank hold AZN as of Q1 2020.

Bell Rock Capital reported no remaining AstraZeneca position as of Q1 2020 after selling out during the quarter.
Bell Rock Capital sold 200 AstraZeneca shares in Q1 2020, an estimated $19K.
Bell Rock Capital first reported a position in AstraZeneca in Q4 2016 and held it in 13 quarters.
Bell Rock Capital's AstraZeneca position peaked at $19K in Q4 2019.
603 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2020.

Based on Bell Rock Capital's 13F filing for Q1 2020, filed 7 May 2020.